Analyze Diet
Analytical and bioanalytical chemistry2009; 394(8); 2119-2128; doi: 10.1007/s00216-009-2912-8

Development of a metabonomic approach based on LC-ESI-HRMS measurements for profiling of metabolic changes induced by recombinant equine growth hormone in horse urine.

Abstract: Despite the worldwide existing regulation banning the use of the recombinant equine growth hormone (reGH) as growth promoter, it is suspected to be used in horseracing to improve performances. Various analytical methods previously developed to screen for its misuse have encountered some limitations in terms of detection timeframes, in particular during the first days following reGH administration. A novel strategy involving the characterization of global metabolomic fingerprints in urine samples of non-treated and reGH-treated horses by liquid chromatography-electrospray-high-resolution mass spectrometry (LC-ESI-HRMS) is described and assessed in this paper in order to develop a new screening tool for growth hormone abuse in horseracing. The strategy involves a limited sample preparation of the urine samples and the use of appropriate software for data processing and analysis. As preliminary work, reproducibility of both sample preparation and mass spectrometry (MS) measurements was evaluated in order to demonstrate the reliability of the method. Application of the developed protocol on two horses demonstrated the suitability of the developed strategy and preliminary results showed significant modifications of the metabolome after treatment with reGH.
Publication Date: 2009-07-08 PubMed ID: 19585110DOI: 10.1007/s00216-009-2912-8Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't
  • Validation Study

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The study focuses on utilizing LC-ESI-HRMS measurements in a new metabonomic approach for profiling metabolic changes induced by the use of recombinant equine growth hormone (reGH) in horse urine – potentially serving as a new screening tool to detect growth hormone abuse in horseracing.

Objective of the Research

  • The main aim of this study is to devise and assess a novel strategy to enhance the detection and screening of recombinant equine growth hormone (reGH) abuse in horseracing. Despite being banned as a growth promoter, reGH is suspected to be used illicitly in horseracing to enhance performances. However, existing analytical methods usually face limitations in detecting it, especially within the first few days of administration. This research targets those limitations by developing a metabonomic approach using LC-ESI-HRMS measurements.

Research Methodology

  • The researchers deployed liquid chromatography-electrospray-high-resolution mass spectrometry (LC-ESI-HRMS) to characterize global metabolomic fingerprints in the urine samples of both non-treated and reGH-treated horses. The resulting profiles help track the metabolic changes induced by the growth hormone.
  • The method involved a simplified, yet effective, sample preparation of the urine samples and the use of specialized software for data processing and examination. This approach minimized manual effort and facilitated greater accuracy.
  • As part of the preliminary work, the researchers evaluated the reproducibility of both the sample preparation and mass spectrometry (MS) measurements to validate the reliability of the proposed method.

Findings and Conclusion

  • The developed protocol was applied to two horses and the results showed the method’s suitability for the intended purpose.
  • The preliminary results indicated that substantial alterations of the metabolome happened post-treatment with reGH, which the method could successfully identify.
  • The researchers conclude by highlighting the potential of this novel metabonomic approach providing a promising new tool for detecting growth hormone abuse in horseracing. It tackles the shortcomings of conventional methods, particularly their inability to detect the hormone during the first few days after application.

Cite This Article

APA
Kieken F, Pinel G, Antignac JP, Monteau F, Christelle Paris A, Popot MA, Bonnaire Y, Le Bizec B. (2009). Development of a metabonomic approach based on LC-ESI-HRMS measurements for profiling of metabolic changes induced by recombinant equine growth hormone in horse urine. Anal Bioanal Chem, 394(8), 2119-2128. https://doi.org/10.1007/s00216-009-2912-8

Publication

ISSN: 1618-2650
NlmUniqueID: 101134327
Country: Germany
Language: English
Volume: 394
Issue: 8
Pages: 2119-2128

Researcher Affiliations

Kieken, Fanny
  • Laboratoire d'Etude des Résidus et Contaminants dans les Aliments (LABERCA), USC INRA 2013, Ecole Nationale Vétérinaire de Nantes (ENV), BP 50707, 44307 Nantes cedex 3, France.
Pinel, Gaud
    Antignac, Jean-Philippe
      Monteau, Fabrice
        Christelle Paris, Anne
          Popot, Marie-Agnès
            Bonnaire, Yves
              Le Bizec, Bruno

                MeSH Terms

                • Animals
                • Chromatography, Liquid / economics
                • Chromatography, Liquid / methods
                • Growth Hormone / administration & dosage
                • Growth Hormone / pharmacology
                • Growth Hormone / urine
                • Horses / urine
                • Metabolome / drug effects
                • Metabolomics / economics
                • Metabolomics / methods
                • Multivariate Analysis
                • Reproducibility of Results
                • Sensitivity and Specificity
                • Spectrometry, Mass, Electrospray Ionization / economics
                • Spectrometry, Mass, Electrospray Ionization / methods

                Citations

                This article has been cited 7 times.
                1. Cloteau C, Dervilly G, Loup B, Delcourt V, Kaabia Z, Bagilet F, Groseille G, Dauriac K, Fisher S, Popot MA, Garcia P, Le Bizec B, Bailly-Chouriberry L. Performance assessment of an equine metabolomics model for screening a range of anabolic agents.. Metabolomics 2023 Apr 7;19(4):38.
                  doi: 10.1007/s11306-023-01985-0pubmed: 37027080google scholar: lookup
                2. Raux A, Bichon E, Benedetto A, Pezzolato M, Bozzetta E, Le Bizec B, Dervilly G. The Promise and Challenges of Determining Recombinant Bovine Growth Hormone in Milk.. Foods 2022 Jan 20;11(3).
                  doi: 10.3390/foods11030274pubmed: 35159426google scholar: lookup
                3. Stastny K, Putecova K, Leva L, Franek M, Dvorak P, Faldyna M. Profiling of Metabolomic Changes in Plasma and Urine of Pigs Caused by Illegal Administration of Testosterone Esters.. Metabolites 2020 Jul 27;10(8).
                  doi: 10.3390/metabo10080307pubmed: 32727023google scholar: lookup
                4. Patterson Rosa L, Mallicote MF, Long MT, Brooks SA. Metabogenomics reveals four candidate regions involved in the pathophysiology of Equine Metabolic Syndrome.. Mol Cell Probes 2020 Oct;53:101620.
                  doi: 10.1016/j.mcp.2020.101620pubmed: 32659253google scholar: lookup
                5. Yuan M, Breitkopf SB, Asara JM. Serial-omics characterization of equine urine.. PLoS One 2017;12(10):e0186258.
                  doi: 10.1371/journal.pone.0186258pubmed: 29028822google scholar: lookup
                6. Ghaste M, Mistrik R, Shulaev V. Applications of Fourier Transform Ion Cyclotron Resonance (FT-ICR) and Orbitrap Based High Resolution Mass Spectrometry in Metabolomics and Lipidomics.. Int J Mol Sci 2016 May 25;17(6).
                  doi: 10.3390/ijms17060816pubmed: 27231903google scholar: lookup
                7. Wei X, Sun W, Shi X, Koo I, Wang B, Zhang J, Yin X, Tang Y, Bogdanov B, Kim S, Zhou Z, McClain C, Zhang X. MetSign: a computational platform for high-resolution mass spectrometry-based metabolomics.. Anal Chem 2011 Oct 15;83(20):7668-75.
                  doi: 10.1021/ac2017025pubmed: 21932828google scholar: lookup